RCL vs VERA · P/E 26, rev $9.28B vs $2.51B cap
Royal Caribbean Cruises Ltd (RCL) versus Vera Therapeutics Inc (VERA) — a side-by-side from cached financials, not a winner call.
Royal Caribbean Cruises Ltd (RCL) is a travel services company listed on US.
Vera Therapeutics Inc (VERA) is a biotechnology company listed on NASDAQ.
Latest reported RCL revenue for 2026-06-30 was $9.28B. Net income was $2.07B. RCL currently screens at market cap $85.57B and trailing P/E 25.7.
VERA does not have a complete income-statement cache yet.
RCL currently screens at market cap $85.57B and trailing P/E 25.7. VERA currently screens at market cap $2.51B.
Not investment advice. Open the RCL and VERA stock pages for the full models.
Not investment advice.